Comparative study of the effect of labetalol and remifentanil on pain control after bariatric surgery
Not Applicable
- Conditions
- Postoperative pain.
- Registration Number
- IRCT20190929044924N3
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
American Society of Anesthesiologists (ASA) class I-II-III
No contraindications and allergies to remifentanil or labetalol
Exclusion Criteria
Patients with cardiac arrhythmias
Pregnant or Breastfeeding women
People with a history of alcohol or drug use in the last 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain severity. Timepoint: Upon entering recovery, 2, 4, 6 and 12 hours after surgery. Method of measurement: Verbal Ranking Scale (VRS).
- Secondary Outcome Measures
Name Time Method